Literature DB >> 6619959

Delayed renal localization of Ga-67: concise communication.

D S Lin, J A Sanders, B R Patel.   

Abstract

Five hundred Ga-67 images, requested for detection or follow-up of inflammatory or neoplastic diseases, were reviewed to evaluate the incidence of delayed renal localization and the clinical significance of different degrees of uptake. Renal uptake in 48- or 72-hr images was graded as follows: 0 = background activity; 1+ = greater than background but less than spine; 2+ = close to spine but less than liver; 3+ = same as liver; 4+ = greater than liver. On the 500 images, 996 kidneys were evaluated and among them 600 (60%) had 0 uptake and 340 (34%) had 1+. These 940 kidneys were all considered to be normal. Fifty-six (6%) had 2+ or more uptake, with possible causes for uptake being: infection 27, drug-induced renal damage ten, urinary stasis or slow excretion seven, collagen vascular disease six, renal failure four, acute tubular necrosis one (ATN), and indeterminate one. Cases of renal infection or failure tended to show more or less 4+ uptake, while drug damage, ATN, or urinary stasis tended to have 2+ uptake.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619959

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Pantoprazole-induced acute interstitial nephritis.

Authors:  Sheila Klassen; Joan C Krepinsky; Ally P H Prebtani
Journal:  CMAJ       Date:  2012-10-29       Impact factor: 8.262

Review 2.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

3.  Association between diffuse renal uptake of 18F-FDG and acute kidney injury.

Authors:  Eitaro Kidera; Sho Koyasu; Nobuyuki Hayakawa; Takayoshi Ishimori; Yuji Nakamoto
Journal:  Ann Nucl Med       Date:  2022-01-06       Impact factor: 2.668

Review 4.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.